Targeting of immunosuppressive myeloid cells from glioblastoma patients by modulation of size and surface charge of lipid nanocapsules

BACKGROUND: Myeloid derived suppressor cells (MDSCs) and tumor-associated macrophages (TAMs) are two of the major players involved in the inhibition of anti-tumor immune response in cancer patients, leading to poor prognosis. Selective targeting of myeloid cells has therefore become an attractive th...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinton, Laura, Magri, Sara, Masetto, Elena, Vettore, Marina, Schibuola, Ilaria, Ingangi, Vincenzo, Marigo, Ilaria, Matha, Kevin, Benoit, Jean-Pierre, Della Puppa, Alessandro, Bronte, Vincenzo, Lollo, Giovanna, Mandruzzato, Susanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026969/
https://www.ncbi.nlm.nih.gov/pubmed/32066449
http://dx.doi.org/10.1186/s12951-020-00589-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026969/
https://www.ncbi.nlm.nih.gov/pubmed/32066449
http://dx.doi.org/10.1186/s12951-020-00589-3

Ejemplares similares